Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care.
Conteduca V, Di Tullio P, Allamprese R, Bruno G, Lolli C, Schepisi G, Rosano A, Giordano G, Garofoli M, Chiuri VE, Fratino L, Zanardi E, Galli L, Massari F, Falagario U, Rescigno P, Fornarini G, Sanguedolce F, Santini D, Procopio G, Caffo O, Carrieri G, Landriscina M, De Giorgi U. Conteduca V, et al. Among authors: lolli c. Prostate Cancer Prostatic Dis. 2024 Feb 12. doi: 10.1038/s41391-024-00800-8. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38347113
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS).
Saponara M, Urbini M, Astolfi A, Indio V, Ercolani G, Del Gaudio M, Santini D, Pirini MG, Fiorentino M, Nannini M, Lolli C, Mandrioli A, Gatto L, Brandi G, Biasco G, Pinna AD, Pantaleo MA. Saponara M, et al. Among authors: lolli c. Oncotarget. 2015 Dec 8;6(39):42243-57. doi: 10.18632/oncotarget.6278. Oncotarget. 2015. PMID: 26544626 Free PMC article.
Taxane-related nail toxicity.
Schepisi G, Conteduca V, Lolli C, Medri M, De Giorgi U. Schepisi G, et al. Among authors: lolli c. Lancet Oncol. 2015 Jul;16(7):e310-1. doi: 10.1016/S1470-2045(15)00019-4. Lancet Oncol. 2015. PMID: 26149877 No abstract available.
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.
Conteduca V, Caffo O, Fratino L, Lo Re G, Basso U, D'Angelo A, Donini M, Verderame F, Ratta R, Procopio G, Campadelli E, Massari F, Gasparro D, Ermacora P, Messina C, Giordano M, Alesini D, Zagonel V, Veccia A, Lolli C, Maines F, De Giorgi U. Conteduca V, et al. Among authors: lolli c. Future Oncol. 2015;11(21):2881-91. doi: 10.2217/fon.15.158. Epub 2015 Oct 5. Future Oncol. 2015. PMID: 26436290
Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus.
Conteduca V, Santoni M, Medri M, Scarpi E, Burattini L, Lolli C, Rossi L, Savini A, Berardi R, Stanganelli I, Cascinu S, De Giorgi U. Conteduca V, et al. Among authors: lolli c. Clin Genitourin Cancer. 2016 Oct;14(5):426-431. doi: 10.1016/j.clgc.2016.02.012. Epub 2016 Feb 23. Clin Genitourin Cancer. 2016. PMID: 27021585
Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31.
Conteduca V, Lolli C, De Giorgi U. Conteduca V, et al. Among authors: lolli c. Eur Urol. 2016 Dec;70(6):e168-e169. doi: 10.1016/j.eururo.2016.05.028. Epub 2016 May 30. Eur Urol. 2016. PMID: 27255584 No abstract available.
120 results